Download PDF
Clin Colon Rectal Surg 2018; 31(06): 347-352
DOI: 10.1055/s-0038-1668104
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Anal Intraepithelial Neoplasia and Squamous Cell Cancer of the Anus

Rebecca E. Hoedema
1   Department of Colorectal Surgery, Michigan State University College of Human Medicine, Grand Rapids, Michigan
2   Department of Colorectal Surgery, Spectrum Health Medical Group/Ferguson Clinic, Grand Rapids, Michigan
› Author Affiliations
Further Information

Publication History

Publication Date:
02 November 2018 (online)

    Permissions and Reprints

Abstract

Anal intraepithelial neoplasia (AIN) is the premalignant condition of the anal squamous tissue. It is associated with the human papilloma virus and is considered the transition prior to the invasive anal squamous cell carcinoma. It is typically asymptomatic and can be either an incidental finding after anorectal surgery or identified when high-risk patient populations are screened. Once AIN is diagnosed, the optimal management remains controversial, partly because the natural history of the disease is unclear. Surgical management of the disease has essentially been replaced by more conservative treatment options and can range from expectant management to topical therapy to photodynamic therapy. The aim of this article is to review the varied treatment options and to briefly review prevention strategies.

Keywords

anal intraepithelial neoplasia - imiquimod - 5-fluorouracil - wide local excision - photodynamic therapy - human papilloma virus
 

  • References

  • 1 Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62 (01) 10-29
    CrossrefPubMedGoogle Scholar
  • 2 Palefsky JM. Human papillomavirus infection and anogenital neoplasia in human immunodeficiency virus-positive men and women. J Natl Cancer Inst Monogr 1998; 23 (23) 15-20
    PubMedGoogle Scholar
  • 3 Machalek DA, Poynten M, Jin F. , et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 2012; 13 (05) 487-500
    CrossrefPubMedGoogle Scholar
  • 4 Oriel JD, Whimster IW. Carcinoma in situ associated with virus-containing anal warts. Br J Dermatol 1971; 84 (01) 71-73
    CrossrefPubMedGoogle Scholar
  • 5 Fenger C, Nielsen VT. Dysplastic changes in the anal canal epithelium in minor surgical specimens. Acta Pathol Microbiol Scand [A] 1981; 89 (06) 463-465
    PubMedGoogle Scholar
  • 6 Darragh TM, Winkler B. Anal cancer and cervical cancer screening: key differences. Cancer Cytopathol 2011; 119 (01) 5-19
    CrossrefPubMedGoogle Scholar
  • 7 Frisch M, Glimelius B, van den Brule AJ. , et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337 (19) 1350-1358
    CrossrefPubMedGoogle Scholar
  • 8 Abbasakoor F, Boulos PB. Anal intraepithelial neoplasia. Br J Surg 2005; 92 (03) 277-290
    CrossrefPubMedGoogle Scholar
  • 9 Steele SR, Varma MG, Melton GB, Ross HM, Rafferty JF, Buie WD. ; Standards Practice Task Force of the American Society of Colon and Rectal Surgeons. Practice parameters for anal squamous neoplasms. Dis Colon Rectum 2012; 55 (07) 735-749
    CrossrefPubMedGoogle Scholar
  • 10 Pineda CE, Berry JM, Jay N, Palefsky JM, Welton ML. High-resolution anoscopy targeted surgical destruction of anal high-grade squamous intraepithelial lesions: a ten-year experience. Dis Colon Rectum 2008; 51 (06) 829-835 , discussion 835–837
    CrossrefPubMedGoogle Scholar
  • 11 Goldman S, Auer G, Erhardt K, Seligson U. Prognostic significance of clinical stage, histologic grade, and nuclear DNA content in squamous-cell carcinoma of the anus. Dis Colon Rectum 1987; 30 (06) 444-448
    CrossrefPubMedGoogle Scholar
  • 12 Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 2004; 101 (02) 281-288
    CrossrefPubMedGoogle Scholar
  • 13 Watson AJ, Smith BB, Whitehead MR, Sykes PH, Frizelle FA. Malignant progression of anal intra-epithelial neoplasia. ANZ J Surg 2006; 76 (08) 715-717
    CrossrefPubMedGoogle Scholar
  • 14 Devaraj B, Cosman BC. Expectant management of anal squamous dysplasia in patients with HIV. Dis Colon Rectum 2006; 49 (01) 36-40
    CrossrefPubMedGoogle Scholar
  • 15 Scholefield JH, Castle MT, Watson NF. Malignant transformation of high-grade anal intraepithelial neoplasia. Br J Surg 2005; 92 (09) 1133-1136
    CrossrefPubMedGoogle Scholar
  • 16 Duong TH, Flowers LC. Vulvo-vaginal cancers: risks, evaluation, prevention and early detection. Obstet Gynecol Clin North Am 2007; 34 (04) 783-802 , x
    CrossrefPubMedGoogle Scholar
  • 17 Sobhani I, Walker F, Roudot-Thoraval F. , et al. Anal carcinoma: incidence and effect of cumulative infections. AIDS 2004; 18 (11) 1561-1569
    CrossrefPubMedGoogle Scholar
  • 18 Love WE, Bernhard JD, Bordeaux JS. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review. Arch Dermatol 2009; 145 (12) 1431-1438
    PubMedGoogle Scholar
  • 19 Ganjian S, Ourian AJ, Shamtoub G, Wu JJ, Murase JE. Off-label indications for imiquimod. Dermatol Online J 2009; 15 (05) 4
    PubMedGoogle Scholar
  • 20 Gutzmer R, Kaspari M, Vogelbruch M. , et al. Successful treatment of anogenital Bowen's disease with the immunomodulator imiquimod, and monitoring of therapy by DNA image cytometry. Br J Dermatol 2002; 147 (01) 160-165
    CrossrefPubMedGoogle Scholar
  • 21 Kreuter A, Hochdorfer B, Stücker M. , et al. Treatment of anal intraepithelial neoplasia in patients with acquired HIV with imiquimod 5% cream. J Am Acad Dermatol 2004; 50 (06) 980-981
    PubMedGoogle Scholar
  • 22 Wieland U, Brockmeyer NH, Weissenborn SJ. , et al. Imiquimod treatment of anal intraepithelial neoplasia in HIV-positive men. Arch Dermatol 2006; 142 (11) 1438-1444
    CrossrefPubMedGoogle Scholar
  • 23 Fox PA, Nathan M, Francis N. , et al. A double-blind, randomized controlled trial of the use of imiquimod cream for the treatment of anal canal high-grade anal intraepithelial neoplasia in HIV-positive MSM on HAART, with long-term follow-up data including the use of open-label imiquimod. AIDS 2010; 24 (15) 2331-2335
    CrossrefPubMedGoogle Scholar
  • 24 Workowski KA, Bolan GA. ; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64 (RR-03): 1-137
    CrossrefPubMedGoogle Scholar
  • 25 Schmidt KU, Wiskemann A, Mensing H. Etretinate and 5-fluorouracil in intra-anal Bowen's disease [in German]. Hautarzt 1986; 37 (05) 278-280
    PubMedGoogle Scholar
  • 26 Richel O, Wieland U, de Vries HJ. , et al. Topical 5-fluorouracil treatment of anal intraepithelial neoplasia in human immunodeficiency virus-positive men. Br J Dermatol 2010; 163 (06) 1301-1307
    CrossrefPubMedGoogle Scholar
  • 27 Graham BD, Jetmore AB, Foote JE, Arnold LK. Topical 5-fluorouracil in the management of extensive anal Bowen's disease: a preferred approach. Dis Colon Rectum 2005; 48 (03) 444-450
    CrossrefPubMedGoogle Scholar
  • 28 Snyder SM, Siekas L, Aboulafia DM. Initial experience with topical fluorouracil for treatment of HIV-associated anal intraepithelial neoplasia. J Int Assoc Physicians AIDS Care (Chic) 2011; 10 (02) 83-88
    CrossrefPubMedGoogle Scholar
  • 29 Cox NH, Eedy DJ, Morton CA. ; Therapy Guidelines and Audit Subcommittee, British Association of Dermatologists. Guidelines for management of Bowen's disease: 2006 update. Br J Dermatol 2007; 156 (01) 11-21
    CrossrefPubMedGoogle Scholar
  • 30 Bargman H, Hochman J. Topical treatment of Bowen's disease with 5-Fluorouracil. J Cutan Med Surg 2003; 7 (02) 101-105
    CrossrefPubMedGoogle Scholar
  • 31 Weis SE. Current treatment options for management of anal intraepithelial neoplasia. Onco Targets Ther 2013; 6: 651-665
    PubMedGoogle Scholar
  • 32 Jay N, Berry JM, Hogeboom CJ, Holly EA, Darragh TM, Palefsky JM. Colposcopic appearance of anal squamous intraepithelial lesions: relationship to histopathology. Dis Colon Rectum 1997; 40 (08) 919-928
    CrossrefPubMedGoogle Scholar
  • 33 Cho SD, Groves E, Lao VV. History of high-resolution anoscopy. Clin Col Rec Surg 2018; 31 (06) 336-346
    PubMedGoogle Scholar
  • 34 Singh JC, Kuohung V, Palefsky JM. Efficacy of trichloroacetic acid in the treatment of anal intraepithelial neoplasia in HIV-positive and HIV-negative men who have sex with men. J Acquir Immune Defic Syndr 2009; 52 (04) 474-479
    PubMedGoogle Scholar
  • 35 Petrelli NJ, Cebollero JA, Rodriguez-Bigas M, Mang T. Photodynamic therapy in the management of neoplasms of the perianal skin. Arch Surg 1992; 127 (12) 1436-1438
    PubMedGoogle Scholar
  • 36 Goldstone SE, Kawalek AZ, Huyett JW. Infrared coagulator: a useful tool for treating anal squamous intraepithelial lesions. Dis Colon Rectum 2005; 48 (05) 1042-1054
    CrossrefPubMedGoogle Scholar
  • 37 Allison RR, Sheng C, Cuenca R, Bagnato VS, Austerlitz C, Sibata CH. Photodynamic therapy for anal cancer. Photodiagn Photodyn Ther 2010; 7 (02) 115-119
    CrossrefPubMedGoogle Scholar
  • 38 Kruijt B, van der Snoek EM, Sterenborg HJ, Amelink A, Robinson DJ. A dedicated applicator for light delivery and monitoring of PDT of intra-anal intraepithelial neoplasia. Photodiagn Photodyn Ther 2010; 7 (01) 3-9
    CrossrefPubMedGoogle Scholar
  • 39 van der Snoek EM, Amelink A, van der Ende ME. , et al. Photodynamic therapy with topical metatetrahydroxychlorin (Fosgel) is ineffective for the treatment of anal intraepithelial neoplasia, grade III. J Acquir Immune Defic Syndr 2009; 52 (01) 141-143
    CrossrefPubMedGoogle Scholar
  • 40 Hamdan KA, Tait IS, Nadeau V, Padgett M, Carey F, Steele RJ. Treatment of grade III anal intraepithelial neoplasia with photodynamic therapy: report of a case. Dis Colon Rectum 2003; 46 (11) 1555-1559
    CrossrefPubMedGoogle Scholar
  • 41 Strauss RJ, Fazio VW. Bowen's disease of the anal and perianal area. A report and analysis of twelve cases. Am J Surg 1979; 137 (02) 231-234
    CrossrefPubMedGoogle Scholar
  • 42 Stier EA, Goldstone SE, Berry JM. , et al. Infrared coagulator treatment of high-grade anal dysplasia in HIV-infected individuals: an AIDS malignancy consortium pilot study. J Acquir Immune Defic Syndr 2008; 47 (01) 56-61
    CrossrefPubMedGoogle Scholar
  • 43 Cranston RD, Hirschowitz SL, Cortina G, Moe AA. A retrospective clinical study of the treatment of high-grade anal dysplasia by infrared coagulation in a population of HIV-positive men who have sex with men. Int J STD AIDS 2008; 19 (02) 118-120
    CrossrefPubMedGoogle Scholar
  • 44 Goldstone RN, Goldstone AB, Russ J, Goldstone SE. Long-term follow-up of infrared coagulator ablation of anal high-grade dysplasia in men who have sex with men. Dis Colon Rectum 2011; 54 (10) 1284-1292
    CrossrefPubMedGoogle Scholar
  • 45 Weis SE, Vecino I, Pogoda JM, Susa JS. Treatment of high-grade anal intraepithelial neoplasia with infrared coagulation in a primary care population of HIV-infected men and women. Dis Colon Rectum 2012; 55 (12) 1236-1243
    CrossrefPubMedGoogle Scholar
  • 46 Cleary RK, Schaldenbrand JD, Fowler JJ, Schuler JM, Lampman RM. Perianal Bowen's disease and anal intraepithelial neoplasia: review of the literature. Dis Colon Rectum 1999; 42 (07) 945-951
    CrossrefPubMedGoogle Scholar
  • 47 Cleary RK, Schaldenbrand JD, Fowler JJ, Schuler JM, Lampman RM. Treatment options for perianal Bowen's disease: survey of American Society of Colon and Rectal Surgeons Members. Am Surg 2000; 66 (07) 686-688
    PubMedGoogle Scholar
  • 48 Hoots BE, Palefsky JM, Pimenta JM, Smith JS. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009; 124 (10) 2375-2383
    CrossrefPubMedGoogle Scholar
  • 49 Gohy L, Gorska I, Rouleau D. , et al; HIPVIRG Study Group. Genotyping of human papillomavirus DNA in anal biopsies and anal swabs collected from HIV-seropositive men with anal dysplasia. J Acquir Immune Defic Syndr 2008; 49 (01) 32-39
    CrossrefPubMedGoogle Scholar
  • 50 Garland SM, Hernandez-Avila M, Wheeler CM. , et al; Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007; 356 (19) 1928-1943
    CrossrefPubMedGoogle Scholar
  • 51 Palefsky JM, Giuliano AR, Goldstone S. , et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011; 365 (17) 1576-1585
    CrossrefPubMedGoogle Scholar